IMUX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.50%

Insider Buying (Last 12 Months): $52,070.00

Insider Selling (Last 12 Months): $0.00

Immunic Insider Trading History Chart

Immunic Share Price & Price History

^$1.38

▲ +0.0094 (0.69%)

As of 09/22/2023 10:41 AM ET

Days: 30 | 90 | 365

Transform Your Portfolio With This Simple Morning Trade!

From Base Camp Trading | Ad

Hi, I’m trading expert Dave Aquino and I want to show you how to take advantage of a trading opportunity happening nearly every morning at 9:30 EST.

My free guide, “How To Master The Retirement Trade” will show you exactly why traders in the know want to keep this trade a secret.

Claim your copy now!

Immunic Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2023	Glenn Whaley	CFO	Buy	5,000	$1.75	$8,750.00	25,510
11/23/2022	Joerg Neermann	Director	Buy	18,000	$1.39	$25,020.00	18,000
11/22/2022	Daniel Vitt	CEO	Buy	8,000	$1.35	$10,800.00	376,877
11/7/2022	Glenn Whaley	CFO	Buy	5,000	$1.50	$7,500.00	20,510
6/3/2022	Daniel Vitt	CEO	Buy	5,000	$3.10	$15,500.00	368,877
6/3/2022	Glenn Whaley	CFO	Buy	3,500	$3.04	$10,640.00	12,568
5/12/2022	Andreas Muehler	Insider	Buy	3,500	$5.10	$17,850.00	297,986
5/12/2022	Andreas Muehler	Insider	Buy	3,500	$5.10	$17,850.00	297,986
5/12/2022	Duane Nash	Chairman	Buy	10,000	$5.03	$50,300.00	22,032
5/12/2022	Glenn Whaley	CFO	Buy	3,000	$5.08	$15,240.00	9,068
8/10/2021	Daniel Vitt	CEO	Buy	1,000	$9.60	$9,600.00	15,032
8/10/2021	Glenn Whaley	Insider	Buy	1,500	$9.85	$14,775.00	3,500
5/12/2021	Duane Nash	Chairman	Buy	4,000	$12.75	$51,000.00	14,032

No Matter The Market, Options Trading Could Earn You More

From Tradewins | Ad

There’s no way to predict Wall Street’s future, but by using options trading, you have the opportunity to take advantage of any trend. Expert Wendy Kirkland explains how in her latest free guide.

Download it for free here!

SEC Filings (Institutional Ownership Changes) for Immunic (NASDAQ:IMUX)

45.26% of Immunic stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunic Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/23/2023	Wolverine Trading LLC	18,150	$42K	0.0%	N/A	0.041%
8/15/2023	XTX Topco Ltd	219,451	$0.55M	0.1%	+210.1%	0.492%
8/14/2023	Two Sigma Securities LLC	14,346	$36K	0.0%	N/A	0.032%
8/14/2023	Schonfeld Strategic Advisors LLC	174,900	$0.44M	0.0%	+31.5%	0.392%
8/14/2023	Deep Track Capital LP	308,314	$0.77M	0.0%	-87.8%	0.691%
8/11/2023	Renaissance Technologies LLC	154,900	$0.39M	0.0%	-59.0%	0.347%
8/11/2023	BlackRock Inc.	377,503	$0.95M	0.0%	+2.5%	0.846%
8/11/2023	Geode Capital Management LLC	353,210	$0.89M	0.0%	-4.2%	0.792%
8/11/2023	Northern Trust Corp	110,588	$0.28M	0.0%	+13.2%	0.248%
8/8/2023	Balboa Wealth Partners	12,000	$30K	0.0%	N/A	0.027%
8/7/2023	Acadian Asset Management LLC	597,277	$1.50M	0.0%	+439.2%	1.339%
8/3/2023	Innovis Asset Management LLC	186,240	$0.47M	0.2%	+130.6%	0.419%
8/3/2023	Gratus Capital LLC	1,678,793	$4.21M	0.3%	+1.4%	3.781%
7/31/2023	LPL Financial LLC	11,000	$28K	0.0%	N/A	0.025%
7/27/2023	Virtu Financial LLC	67,424	$0.17M	0.0%	N/A	0.152%
7/24/2023	Vontobel Holding Ltd.	10,000	$25K	0.0%	N/A	0.023%
5/16/2023	State Street Corp	125,803	$0.19M	0.0%	+63.0%	0.283%
5/16/2023	Geode Capital Management LLC	368,635	$0.55M	0.0%	+36.3%	0.830%
5/15/2023	Schonfeld Strategic Advisors LLC	133,000	$0.20M	0.0%	N/A	0.300%
5/15/2023	Logos Global Management LP	421,184	$0.63M	0.1%	N/A	0.949%
5/15/2023	Two Sigma Advisers LP	400,318	$0.60M	0.0%	-29.3%	0.902%
5/15/2023	Two Sigma Investments LP	290,668	$0.43M	0.0%	+3.4%	0.655%
5/15/2023	RTW Investments LP	4,294,459	$6.40M	0.1%	+11.2%	9.671%
5/15/2023	XTX Topco Ltd	70,767	$0.11M	0.0%	N/A	0.159%
5/12/2023	Renaissance Technologies LLC	377,460	$0.56M	0.0%	N/A	0.850%
5/12/2023	Bank of America Corp DE	90,533	$0.14M	0.0%	-78.8%	0.204%
5/12/2023	Charles Schwab Investment Management Inc.	25,000	$37K	0.0%	N/A	0.056%
5/11/2023	Acadian Asset Management LLC	110,774	$0.16M	0.0%	-23.4%	0.249%
5/10/2023	Innovis Asset Management LLC	80,773	$0.12M	0.0%	N/A	0.182%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	86,907	$0.13M	0.0%	N/A	0.196%
5/9/2023	Cowen AND Company LLC	357,855	$0.53M	0.1%	-54.8%	0.806%
5/4/2023	Barclays PLC	68,740	$0.10M	0.0%	-13.4%	0.155%
4/20/2023	Gratus Capital LLC	1,655,405	$2.47M	0.2%	-0.8%	3.728%
2/15/2023	Silverarc Capital Management LLC	350,656	$0.49M	0.1%	N/A	0.790%
2/15/2023	Millennium Management LLC	731,544	$1.02M	0.0%	-39.5%	1.649%
2/15/2023	Morgan Stanley	474,377	$0.66M	0.0%	+2,552.4%	1.069%
2/15/2023	Boothbay Fund Management LLC	117,130	$0.16M	0.0%	N/A	0.264%
2/14/2023	Point72 Asset Management L.P.	714,655	$1M	0.0%	-46.1%	1.611%
2/14/2023	RA Capital Management L.P.	632,184	$0.89M	0.0%	N/A	1.425%
2/14/2023	Verition Fund Management LLC	527,633	$0.74M	0.0%	-24.5%	1.189%
2/14/2023	Marshall Wace LLP	97,486	$0.14M	0.0%	+300.0%	0.220%
2/14/2023	Two Sigma Investments LP	281,065	$0.39M	0.0%	+156.1%	0.634%
2/13/2023	Vivo Capital LLC	632,184	$0.83M	0.1%	N/A	1.425%
2/13/2023	Barclays PLC	79,368	$0.11M	0.0%	N/A	0.179%
2/13/2023	Geode Capital Management LLC	270,481	$0.38M	0.0%	+24.8%	0.610%
2/13/2023	GSA Capital Partners LLP	79,186	$0.11M	0.0%	+166.4%	0.179%
2/13/2023	JPMorgan Chase & Co.	24,903	$35K	0.0%	+1,143.9%	0.056%
2/13/2023	Artal Group S.A.	1,274,713	$1.79M	0.1%	+82.1%	2.874%
2/10/2023	Bank of America Corp DE	426,652	$0.60M	0.0%	+5,328.8%	0.962%
2/9/2023	Cowen AND Company LLC	791,024	$1.11M	0.1%	-34.1%	1.783%
1/27/2023	Gratus Capital LLC	1,668,294	$2.34M	0.2%	+121.5%	3.761%
11/15/2022	Jacobs Levy Equity Management Inc.	25,421	$80K	0.0%	N/A	0.065%
11/15/2022	Two Sigma Investments LP	109,760	$0.35M	0.0%	-44.4%	0.280%
11/15/2022	Vanguard Group Inc.	994,671	$3.14M	0.0%	+13.2%	2.533%
11/15/2022	Parkman Healthcare Partners LLC	657,643	$2.08M	0.6%	+1.2%	1.675%
11/15/2022	Marshall Wace LLP	24,373	$77K	0.0%	N/A	0.062%
11/15/2022	Engineers Gate Manager LP	30,444	$96K	0.0%	+123.2%	0.078%
11/14/2022	Lynx1 Capital Management LP	1,072,288	$3.39M	3.1%	-2.9%	2.731%
11/14/2022	Renaissance Technologies LLC	130,665	$0.41M	0.0%	+347.5%	0.333%
11/14/2022	Verition Fund Management LLC	698,934	$2.21M	0.0%	+14.6%	1.780%
11/14/2022	Ergoteles LLC	24,725	$78K	0.0%	-72.6%	0.063%
11/14/2022	UBS Oconnor LLC	197,988	$0.63M	0.0%	-14.9%	0.504%
11/10/2022	Dimensional Fund Advisors LP	29,974	$95K	0.0%	-31.3%	0.076%
11/4/2022	Gratus Capital LLC	753,190	$2.38M	0.3%	N/A	2.464%
10/25/2022	Denali Advisors LLC	17,000	$54K	0.0%	N/A	0.056%
8/30/2022	Verition Fund Management LLC	609,765	$2.12M	0.0%	+331.5%	1.995%
8/18/2022	Goldman Sachs Group Inc.	26,891	$93K	0.0%	-89.1%	0.088%
8/16/2022	Jane Street Group LLC	69,345	$0.24M	0.0%	+402.1%	0.227%
8/16/2022	Corton Capital Inc.	12,142	$42K	0.0%	N/A	0.040%
8/16/2022	Delphia USA Inc.	13,181	$46K	0.0%	N/A	0.043%
8/15/2022	State Street Corp	65,903	$0.23M	0.0%	-79.4%	0.216%
8/15/2022	Point72 Asset Management L.P.	1,325,000	$4.60M	0.0%	+82.8%	4.335%
8/13/2022	Renaissance Technologies LLC	29,200	$0.10M	0.0%	N/A	0.096%
8/12/2022	Northern Trust Corp	75,772	$0.26M	0.0%	-59.7%	0.248%
8/11/2022	UBS Group AG	73,565	$0.26M	0.0%	+9,936.2%	0.241%
8/5/2022	Cowen AND Company LLC	1,200,691	$4.17M	0.4%	-6.3%	3.932%
6/7/2022	Bank of America Corp DE	8,685	$98K	0.0%	-33.8%	0.028%
6/2/2022	Verition Fund Management LLC	141,319	$1.60M	0.0%	-26.2%	0.463%
5/18/2022	BNP Paribas Arbitrage SA	2,285	$26K	0.0%	-68.4%	0.007%
5/17/2022	Jane Street Group LLC	13,812	$0.16M	0.0%	-53.0%	0.045%
5/17/2022	Royal Bank of Canada	2,294	$26K	0.0%	-55.0%	0.008%
5/17/2022	RTW Investments LP	2,705,513	$30.57M	0.6%	+57.7%	8.859%
5/17/2022	Endurant Capital Management LP	130,567	$1.48M	0.4%	-29.2%	0.428%
5/16/2022	California State Teachers Retirement System	7,971	$90K	0.0%	-19.9%	0.026%
5/16/2022	Goldman Sachs Group Inc.	246,121	$2.78M	0.0%	+39.7%	0.806%
5/16/2022	State Street Corp	319,575	$3.61M	0.0%	-31.1%	1.046%
5/13/2022	Silverarc Capital Management LLC	68,475	$0.77M	0.3%	N/A	0.224%
5/13/2022	Northern Trust Corp	188,148	$2.13M	0.0%	+3.0%	0.616%
5/13/2022	Verition Fund Management LLC	141,319	$1.60M	0.0%	-26.2%	0.463%
5/13/2022	Parkman Healthcare Partners LLC	1,089,251	$12.31M	3.6%	+11.8%	3.567%
5/13/2022	DLD Asset Management LP	50,000	$0.57M	0.0%	N/A	0.164%
5/13/2022	Vanguard Group Inc.	956,697	$10.81M	0.0%	+6.1%	3.133%
5/13/2022	Dimensional Fund Advisors LP	46,777	$0.53M	0.0%	+70.8%	0.153%
5/12/2022	BlackRock Inc.	1,314,484	$14.85M	0.0%	+0.9%	4.304%
5/12/2022	Rhumbline Advisers	22,122	$0.25M	0.0%	+30.6%	0.072%
5/12/2022	MetLife Investment Management LLC	11,878	$0.13M	0.0%	N/A	0.039%
5/11/2022	Bank of New York Mellon Corp	78,692	$0.89M	0.0%	-3.5%	0.258%
5/11/2022	JPMorgan Chase & Co.	13,649	$0.15M	0.0%	+21.2%	0.045%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,031	$34K	0.0%	N/A	0.011%
4/18/2022	Golden Green Inc.	32,649	$0.37M	0.3%	-49.7%	0.117%

Data available starting January 2016

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Today's Range

Now: $1.38

$1.34

$1.40

50 Day Range

MA: $1.90

$1.38

$2.72

52 Week Range

Now: $1.38

$1.11

$11.76

Volume

23,453 shs

Average Volume

1,037,765 shs

Market Capitalization

$61.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Who are the company insiders with the largest holdings of Immunic?: Immunic's top insider shareholders include:
Daniel Vitt (CEO)
Andreas Muehler (Insider)
Glenn Whaley (CFO)
Duane Nash (Chairman)
Joerg Neermann (Director)
Learn More about top insider investors at Immunic.
Who are the major institutional investors of Immunic?: Immunic's top institutional shareholders include:
Gratus Capital LLC — 3.78%
Acadian Asset Management LLC — 1.34%
BlackRock Inc. — 0.85%
Geode Capital Management LLC — 0.79%
Deep Track Capital LP — 0.69%
XTX Topco Ltd — 0.49%
Learn More about top institutional investors of Immunic stock.
Which institutional investors are selling Immunic stock?: During the last quarter, IMUX stock was sold by these institutional investors:
Deep Track Capital LP
Renaissance Technologies LLC
Citadel Advisors LLC
Simplex Trading LLC
Geode Capital Management LLC
Which institutional investors are buying Immunic stock?: During the previous quarter, IMUX stock was purchased by institutional investors including:
Acadian Asset Management LLC
XTX Topco Ltd
Innovis Asset Management LLC
Virtu Financial LLC
Schonfeld Strategic Advisors LLC
Gratus Capital LLC
Wolverine Trading LLC
Two Sigma Securities LLC
In the last year, these company insiders have bought Immunic stock:
Daniel Vitt (CEO)
Andreas Muehler (Insider)
Glenn Whaley (CFO)
Duane Nash (Chairman)
Joerg Neermann (Director)
Learn More investors buying Immunic stock.